annual CFO:
-$87.79M-$14.41M(-19.64%)Summary
- As of today (May 29, 2025), VKTX annual cash flow from operations is -$87.79 million, with the most recent change of -$14.41 million (-19.64%) on December 31, 2024.
- During the last 3 years, VKTX annual CFO has fallen by -$40.20 million (-84.49%).
- VKTX annual CFO is now -112163.43% below its all-time high of -$78.20 thousand, reached on December 31, 2013.
Performance
VKTX Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$52.33M-$21.15M(-67.83%)Summary
- As of today (May 29, 2025), VKTX quarterly cash flow from operations is -$52.33 million, with the most recent change of -$21.15 million (-67.83%) on March 31, 2025.
- Over the past year, VKTX quarterly CFO has dropped by -$46.20 million (-753.13%).
Performance
VKTX quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$133.99M-$46.20M(-52.62%)Summary
- As of today (May 29, 2025), VKTX TTM cash flow from operations is -$133.99 million, with the most recent change of -$46.20 million (-52.62%) on March 31, 2025.
- Over the past year, VKTX TTM CFO has dropped by -$79.12 million (-144.20%).
Performance
VKTX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
VKTX Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -19.6% | -753.1% | -144.2% |
| 3 y3 years | -84.5% | -397.0% | -183.6% |
| 5 y5 years | -254.7% | -1116.4% | -417.3% |
VKTX Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -84.5% | at low | -753.1% | at low | -183.6% | at low |
| 5 y | 5-year | -303.1% | at low | -1116.4% | at low | -515.3% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low | <-9999.0% | at low |
VKTX Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$52.33M(+67.8%) | -$133.99M(+52.6%) |
| Dec 2024 | -$87.79M(+19.6%) | -$31.18M(+42.0%) | -$87.79M(+18.2%) |
| Sep 2024 | - | -$21.96M(-23.0%) | -$74.25M(+3.2%) |
| Jun 2024 | - | -$28.51M(+364.8%) | -$71.94M(+31.1%) |
| Mar 2024 | - | -$6.13M(-65.2%) | -$54.87M(-25.2%) |
| Dec 2023 | -$73.38M(+51.6%) | -$17.64M(-10.3%) | -$73.38M(+10.1%) |
| Sep 2023 | - | -$19.66M(+71.9%) | -$66.66M(+10.2%) |
| Jun 2023 | - | -$11.44M(-53.6%) | -$60.50M(-3.2%) |
| Mar 2023 | - | -$24.64M(+125.5%) | -$62.51M(+29.2%) |
| Dec 2022 | -$48.40M(+1.7%) | -$10.93M(-19.1%) | -$48.40M(-2.9%) |
| Sep 2022 | - | -$13.50M(+0.4%) | -$49.82M(+5.4%) |
| Jun 2022 | - | -$13.44M(+27.7%) | -$47.25M(+0.0%) |
| Mar 2022 | - | -$10.53M(-14.7%) | -$47.24M(-0.7%) |
| Dec 2021 | -$47.59M(+118.5%) | -$12.35M(+13.0%) | -$47.59M(+16.9%) |
| Sep 2021 | - | -$10.93M(-18.7%) | -$40.72M(+16.0%) |
| Jun 2021 | - | -$13.43M(+23.5%) | -$35.12M(+23.9%) |
| Mar 2021 | - | -$10.88M(+98.3%) | -$28.35M(+30.2%) |
| Dec 2020 | -$21.78M(-12.0%) | -$5.49M(+3.1%) | -$21.78M(-22.3%) |
| Sep 2020 | - | -$5.32M(-20.1%) | -$28.03M(+7.4%) |
| Jun 2020 | - | -$6.67M(+55.0%) | -$26.11M(+0.8%) |
| Mar 2020 | - | -$4.30M(-63.4%) | -$25.90M(+4.6%) |
| Dec 2019 | -$24.75M | -$11.74M(+245.6%) | -$24.75M(+57.8%) |
| Sep 2019 | - | -$3.40M(-47.4%) | -$15.69M(-11.8%) |
| Jun 2019 | - | -$6.46M(+104.9%) | -$17.79M(+7.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$3.15M(+17.7%) | -$16.60M(-11.5%) |
| Dec 2018 | -$18.75M(+27.1%) | -$2.68M(-51.3%) | -$18.75M(-6.3%) |
| Sep 2018 | - | -$5.50M(+4.4%) | -$20.02M(+12.2%) |
| Jun 2018 | - | -$5.27M(-0.6%) | -$17.85M(+6.4%) |
| Mar 2018 | - | -$5.30M(+34.4%) | -$16.78M(+13.7%) |
| Dec 2017 | -$14.76M(+33.3%) | -$3.95M(+18.6%) | -$14.76M(+11.2%) |
| Sep 2017 | - | -$3.33M(-20.8%) | -$13.28M(+5.4%) |
| Jun 2017 | - | -$4.20M(+28.1%) | -$12.60M(+8.4%) |
| Mar 2017 | - | -$3.28M(+33.1%) | -$11.63M(+5.0%) |
| Dec 2016 | -$11.07M(+26.8%) | -$2.46M(-7.1%) | -$11.07M(-7.0%) |
| Sep 2016 | - | -$2.65M(-17.7%) | -$11.91M(-5.9%) |
| Jun 2016 | - | -$3.23M(+18.4%) | -$12.65M(+14.5%) |
| Mar 2016 | - | -$2.73M(-17.4%) | -$11.05M(+26.5%) |
| Dec 2015 | -$8.73M(+448.7%) | -$3.30M(-3.0%) | -$8.73M(+48.7%) |
| Sep 2015 | - | -$3.40M(+109.8%) | -$5.87M(+90.5%) |
| Jun 2015 | - | -$1.62M(+294.4%) | -$3.08M(+62.1%) |
| Mar 2015 | - | -$410.90K(-6.8%) | -$1.90M(+19.5%) |
| Dec 2014 | -$1.59M(+1935.0%) | -$441.00K(-27.7%) | -$1.59M(+38.3%) |
| Sep 2014 | - | -$609.80K(+38.6%) | -$1.15M(+112.8%) |
| Jun 2014 | - | -$439.90K(+336.4%) | -$540.70K(+388.4%) |
| Mar 2014 | - | -$100.80K(+918.2%) | -$110.70K(+1018.2%) |
| Dec 2013 | -$78.20K | - | - |
| Jun 2013 | - | -$9900.00(<-9900.0%) | -$9900.00(<-9900.0%) |
| Mar 2013 | - | $0.00 | $0.00 |
FAQ
- What is Viking Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Viking Therapeutics?
- What is Viking Therapeutics annual CFO year-on-year change?
- What is Viking Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Viking Therapeutics?
- What is Viking Therapeutics quarterly CFO year-on-year change?
- What is Viking Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Viking Therapeutics?
- What is Viking Therapeutics TTM CFO year-on-year change?
What is Viking Therapeutics annual cash flow from operations?
The current annual CFO of VKTX is -$87.79M
What is the all time high annual CFO for Viking Therapeutics?
Viking Therapeutics all-time high annual cash flow from operations is -$78.20K
What is Viking Therapeutics annual CFO year-on-year change?
Over the past year, VKTX annual cash flow from operations has changed by -$14.41M (-19.64%)
What is Viking Therapeutics quarterly cash flow from operations?
The current quarterly CFO of VKTX is -$52.33M
What is the all time high quarterly CFO for Viking Therapeutics?
Viking Therapeutics all-time high quarterly cash flow from operations is $0.00
What is Viking Therapeutics quarterly CFO year-on-year change?
Over the past year, VKTX quarterly cash flow from operations has changed by -$46.20M (-753.13%)
What is Viking Therapeutics TTM cash flow from operations?
The current TTM CFO of VKTX is -$133.99M
What is the all time high TTM CFO for Viking Therapeutics?
Viking Therapeutics all-time high TTM cash flow from operations is $0.00
What is Viking Therapeutics TTM CFO year-on-year change?
Over the past year, VKTX TTM cash flow from operations has changed by -$79.12M (-144.20%)